On October 15, 2015, the Food and Drug Administration posted notice of a public meeting to be held on Friday October 30th, in order to clarify the current roles and responsibilities described in the Coordinated Framework for the Regulation of Biotechnology and to develop a long-term strategy for the regulation of the products of biotechnology. The meeting notice follows the White House's Office of Science and Technology Policy's July 2015 memorandum announcing a major overhaul of the current biotech regulatory framework.